• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患儿中与耳毒性相关的听力损失

Hearing loss related to ototoxicity in children with cancer.

作者信息

Landier W

机构信息

School of Nursing, University of California, Los Angeles, USA.

出版信息

J Pediatr Oncol Nurs. 1998 Oct;15(4):195-206. doi: 10.1177/104345429801500402.

DOI:10.1177/104345429801500402
PMID:9810786
Abstract

Children undergoing treatment for cancer often receive agents that put them at risk for ototoxicity. Platinum-based chemotherapy, aminoglycoside antibiotics, loop diuretics, and radiotherapy are all capable of inducing inner ear damage, which may result in significant sensorineural hearing loss. Frequent audiological monitoring is necessary for the early detection of changes in hearing thresholds. Age-appropriate modification of audiological testing is essential to obtain accurate results and provide maximum comfort for pediatric patients. When hearing loss is identified promptly, consideration may be given to treatment modification and/or early intervention with hearing aids and other assistive devices. The consequences of hearing loss differ depending on the developmental stage of the child at the time that hearing loss occurs. Language acquisition may be affected in very young children, whereas educational and psychosocial concerns are paramount for the older child. The pediatric oncology nurse is instrumental in assisting the child and family who are coping with hearing loss related to cancer treatment.

摘要

接受癌症治疗的儿童经常会使用一些使其面临耳毒性风险的药物。铂类化疗药物、氨基糖苷类抗生素、袢利尿剂和放射治疗都有可能导致内耳损伤,进而可能导致严重的感音神经性听力损失。频繁进行听力监测对于早期发现听力阈值变化很有必要。根据年龄适当调整听力测试对于获得准确结果以及为儿科患者提供最大程度的舒适感至关重要。当听力损失被及时发现时,可以考虑调整治疗方案和/或尽早使用助听器及其他辅助设备进行干预。听力损失的后果因听力损失发生时儿童的发育阶段而异。对于幼儿来说,语言习得可能会受到影响,而对于年龄较大的儿童,教育和心理社会问题则至关重要。儿科肿瘤护士在帮助应对与癌症治疗相关听力损失的儿童及其家庭方面发挥着重要作用。

相似文献

1
Hearing loss related to ototoxicity in children with cancer.癌症患儿中与耳毒性相关的听力损失
J Pediatr Oncol Nurs. 1998 Oct;15(4):195-206. doi: 10.1177/104345429801500402.
2
Challenges in ototoxicity monitoring in the pediatric oncology population.儿科肿瘤患者群体中耳毒性监测面临的挑战。
J Am Acad Audiol. 2014 Sep;25(8):760-74; quiz 782-3. doi: 10.3766/jaaa.25.8.6.
3
[Hearing loss due to chemotherapy and radiation therapy in young children].[幼儿化疗和放疗导致的听力损失]
Harefuah. 2012 Jan;151(1):24-8, 62.
4
The prevalence of hearing loss in children and adolescents with cancer.癌症患儿及青少年的听力损失患病率。
Braz J Otorhinolaryngol. 2007 Sep-Oct;73(5):608-14. doi: 10.1016/s1808-8694(15)30120-8.
5
Ototoxicity in children receiving platinum chemotherapy: underestimating a commonly occurring toxicity that may influence academic and social development.接受铂类化疗的儿童的耳毒性:低估一种可能影响学业和社交发展的常见毒性。
J Clin Oncol. 2005 Dec 1;23(34):8588-96. doi: 10.1200/JCO.2004.00.5355.
6
Ototoxicity and cancer therapy.耳毒性与癌症治疗。
Cancer. 2016 Jun 1;122(11):1647-58. doi: 10.1002/cncr.29779. Epub 2016 Feb 9.
7
Audiological monitoring in Swiss childhood cancer patients.瑞士儿童癌症患者的听力监测。
Pediatr Blood Cancer. 2018 Mar;65(3). doi: 10.1002/pbc.26877. Epub 2017 Dec 12.
8
Incidence of platinum-induced ototoxicity in pediatric patients in Quebec.魁北克省儿科患者铂类药物所致耳毒性的发生率。
Pediatr Blood Cancer. 2014 Nov;61(11):2012-7. doi: 10.1002/pbc.25123. Epub 2014 Jun 29.
9
Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides.癌症患儿接受氨基糖苷类药物治疗后的听力损失和前庭功能障碍。
Pediatr Blood Cancer. 2013 Nov;60(11):1772-7. doi: 10.1002/pbc.24631. Epub 2013 Jun 20.
10
Preventing platinum-induced ototoxicity in children-is there a potential role for sodium thiosulfate?预防儿童铂类药物所致耳毒性——硫代硫酸钠是否具有潜在作用?
Pediatr Blood Cancer. 2006 Aug;47(2):120-2. doi: 10.1002/pbc.20627.

引用本文的文献

1
Cool OtOprotective Ear Lumen (COOL) Therapy for Cisplatin-induced Hearing Loss.Cool OtOprotective Ear Lumen(COOL)疗法治疗顺铂诱导的听力损失。
Otol Neurotol. 2021 Mar 1;42(3):466-474. doi: 10.1097/MAO.0000000000002948.
2
Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.多机构前瞻性试验:针对平均风险髓母细胞瘤,采用低剂量全脑全脊髓照射(23.4 Gy),随后进行适形后颅窝照射(36 Gy)和原发部位照射(55.8 Gy)以及剂量密集化疗。
Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):782-7. doi: 10.1016/j.ijrobp.2007.07.2342. Epub 2007 Sep 24.